Article

Centricity Vision’s new ZEPTO Plus handpiece gives surgeons a choice in capsulotomy size

CEO Rob Thornhill discusses the features of the device, as well as plans for a new technology called ZEPTOLINK which combines the company’s novel ZEPTO technology with any phaco device.

Video transcript

Note: This transcript has been lightly edited for clarity.

Rob Thornhill: Hello, my name is Rob Thornhill. I'm the CEO of Centricity Vision. We're pleased to announce the introduction of our new ZEPTO Plus handpiece at this year's [American] Academy [of Ophthalmology]. ZEPTO Plus gives our surgeon partners a choice in capsulotomy size when they're working with our automated capsulotomy system.

The ZEPTO Plus creates a 5.4 capsulotomy and allows surgeons to do phaco outside of the capsular bag and also provides a larger capsulotomy for surgeons when they do complex cases. This device provides the same centered, consistent capsulotomies with 360-degree overlap that provides time and cost efficiency in the operating room.

We're also developing a new technology called ZEPTOLINK which combines our ZEPTO technology with any phaco device. This device, when it's completed, will add complete control for the surgeon and the procedure including the capsulotomy through the phaco foot pedal. We are going to the FDA by the end of this year, and we expect if all things go well to be introducing this very exciting new technology by spring 2023.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.